ATE91233T1 - Antivirale pharmazeutische zusammensetzungen und ihrer verwendung. - Google Patents

Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.

Info

Publication number
ATE91233T1
ATE91233T1 AT85102607T AT85102607T ATE91233T1 AT E91233 T1 ATE91233 T1 AT E91233T1 AT 85102607 T AT85102607 T AT 85102607T AT 85102607 T AT85102607 T AT 85102607T AT E91233 T1 ATE91233 T1 AT E91233T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
antiviral pharmaceutical
lidocaine
mammals
humans
Prior art date
Application number
AT85102607T
Other languages
English (en)
Inventor
Harold Gray Haines
Caroline Burgess Dickens
Original Assignee
Brigham Dana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Dana filed Critical Brigham Dana
Application granted granted Critical
Publication of ATE91233T1 publication Critical patent/ATE91233T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT85102607T 1984-03-08 1985-03-07 Antivirale pharmazeutische zusammensetzungen und ihrer verwendung. ATE91233T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/587,398 US4628063A (en) 1984-03-08 1984-03-08 Antiviral pharmaceutical preparations and methods for their use
EP85102607A EP0154344B1 (de) 1984-03-08 1985-03-07 Antivirale pharmazeutische Zusammensetzungen und ihrer Verwendung

Publications (1)

Publication Number Publication Date
ATE91233T1 true ATE91233T1 (de) 1993-07-15

Family

ID=24349633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85102607T ATE91233T1 (de) 1984-03-08 1985-03-07 Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.

Country Status (13)

Country Link
US (2) US4628063A (de)
EP (1) EP0154344B1 (de)
JP (1) JPH0676317B2 (de)
AT (1) ATE91233T1 (de)
AU (1) AU571072B2 (de)
DE (1) DE3587434T2 (de)
ES (1) ES8700053A1 (de)
IE (1) IE61525B1 (de)
IL (1) IL74535A (de)
NZ (1) NZ211361A (de)
PT (1) PT80079B (de)
WO (1) WO1985003862A1 (de)
ZA (1) ZA851765B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
SE8804214L (sv) * 1988-11-22 1990-05-23 Jean Cassuto Antiinflammatoriskt och antiinfektioest medikament
US4997853A (en) * 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
JP3115625B2 (ja) * 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
EP0643964A3 (de) * 1993-08-18 1995-08-09 Medipharma Sa Verwendung von Lokalanästhetika zur Herstellung eines Arzneimittels zum Schutz der Membran von Plasmazellen.
CA2130291A1 (en) * 1993-08-18 1995-02-19 Juan Carlos Mahiques Therapeutic uses of known ester and amide compounds
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5776859A (en) * 1995-11-15 1998-07-07 Nickel; Alfred A. Sodium channel active novel compounds and related processes and bioassay techniques
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
DE19823319A1 (de) * 1998-05-26 1999-12-02 Karl Engelhard, Fabrik Pharm.- Praeparate Gmbh & Co. Kg Topisch anwendbares Arzneimittel zur Behandlung von Virusinfektionen
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
KR101108439B1 (ko) 2002-10-25 2012-01-31 포믹스 리미티드 화장료 및 약제용 거품제
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
AU2006298442A1 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
ITRM20060163A1 (it) * 2006-03-24 2007-09-25 Ist Farmacoterapico It Spa Composizione spray ad uso topico per il tratamento e la prevenzione delle infezioni labiali da herpes simplex
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2482788B1 (de) 2009-10-02 2022-12-14 Journey Medical Corporation Topische tetracyclinzusammensetzungen
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
IT201800007009A1 (it) * 2018-07-06 2020-01-06 Nuovo uso medico di anestetici locali

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1315727A (fr) * 1961-06-13 1963-01-25 Perfectionnement aux véhicules-jouets
RO75309A2 (ro) * 1978-10-24 1981-12-25 Intreprinderea De Antibiotice,Ro Unguent medicamentos pentru tratamentul zonei zoster
FR2484257A1 (fr) * 1980-06-16 1981-12-18 Girard Michele Composition polyvitaminee pour le traitement de l'herpes

Also Published As

Publication number Publication date
EP0154344A3 (en) 1990-06-13
IE61525B1 (en) 1994-11-16
AU4067385A (en) 1985-09-24
IL74535A0 (en) 1985-06-30
IE850581L (en) 1985-09-08
NZ211361A (en) 1988-07-28
EP0154344B1 (de) 1993-07-07
DE3587434T2 (de) 1994-02-17
EP0154344A2 (de) 1985-09-11
DE3587434D1 (de) 1993-08-12
US4757088A (en) 1988-07-12
ES8700053A1 (es) 1986-10-16
JPH0676317B2 (ja) 1994-09-28
US4628063A (en) 1986-12-09
IL74535A (en) 1988-12-30
JPS61501325A (ja) 1986-07-03
PT80079A (en) 1985-04-01
ES541103A0 (es) 1986-10-16
PT80079B (pt) 1987-09-18
AU571072B2 (en) 1988-03-31
ZA851765B (en) 1985-11-27
WO1985003862A1 (en) 1985-09-12

Similar Documents

Publication Publication Date Title
ATE91233T1 (de) Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
DE3581819D1 (de) Pyridazinamine wirksam gegen viren.
AR240251A1 (es) Metodo para preparar una composicion para tratamiento de infecciones virales y un metodo para sintetizar 3' azido 2', 3' dideoxiuridina destinada a la preparacion de dicha composicion.
ATE231839T1 (de) Polyaromatische antivirale zusammensetzungen
PT735890E (pt) Misturas de 2',3'-didesoxi-inosina e hidroxicarbamida para inibicao da disseminacao retroviral
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
KR860000867A (ko) 급성 방사선 증후군 발현억제 및 패혈증 발현억제의 방법 및 그 조성물
DE3473272D1 (en) Guanine derivatives, compositions containing them, and their anti-viral use
ES2036526T3 (es) Composiciones de interferon.
ES2181915T3 (es) Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones.
ES2010559A6 (es) Procedimiento de preparacion de composiciones farmaceuticas antivirales de aplicacion externa que se acumulan en la piel.
IT8103423A0 (it) Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono
IT8422646A0 (it) Contengono. composti derivati dell'acido beta-ossimino-propionico adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li
AU1575688A (en) Medicinal composition for treating and preventing diseases caused by cytotoxicity by cellular mediation, incorporating at least one pyridine derivate as active principle
IT8319981A0 (it) Composti ad attivita' antivirale, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
IT8222494A0 (it) Derivati ad attivita'espettorante, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT8224116A0 (it) Composti ad attivita'antiinfiammatoria, processo per laloro preparazione e composizioni farmaceutiche relative.
IT1232796B (it) Composizioni sinergisticamente attive e procedimento per la loro preparazione.
ITMI922832A1 (it) DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.
IT8321358A0 (it) Derivati ad attivita' terapeutica della s-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee